vimarsana.com

Page 23 - நோய்த்தடுப்பு ப்ரோக்ராம் கைரி ஜமாலுதீன் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

(Updated) Malaysia takes delivery of Sinovac Covid-19 vaccine

27 Feb 2021 / 10:30 H. Senior Minister (Security Cluster) Datuk Seri Ismail Sabri Yaakob (third, right) with China’s Ambassador to Malaysia Ouyang Yujing (third, left) at the second supply of COVID-19 vaccine made by biopharmaceutical company from China, Sinovac at the Kuala Lumpur International Airport (KLIA) on Feb 27. Also present Coordinating Minister of the National COVID-19 Immunisation Programme Khairy Jamaluddin (right), Foreign Minister Datuk Seri Hishamuddin Tun Hussein (fourth, left) and Transport Minister Datuk Seri Dr Wee Ka Siong (second, right). - Bernama SEPANG, Feb 27: Malaysia today took delivery of the Sinovac vaccine, another brand of the COVID-19 vaccine it has procured, almost a week after it received the first batch of the Pfizer-BioNTech vaccine.

(Updated) Sinovac vaccine manufacturing process to be evaluated first for approval

Khairy to skip Pfizer vaccine to prove a point

Khairy: National Pharmaceutical Regulatory Agency uncompromising on Covid-19 vaccine quality and safety | Malaysia

Saturday, 27 Feb 2021 08:34 AM MYT Coordinating Minister for National Covid-19 Immunisation Programme Khairy Jamaluddin says the NPRA is described as the most meticulous by the vaccine companies, compared to other international regulatory bodies. Bernama pic Subscribe to our Telegram channel for the latest updates on news you need to know. KUALA LUMPUR, Feb 27 ― The National Pharmaceutical Regulatory Agency (NPRA), which is responsible for the approval of the Covid-19 vaccine in this country, is very particular in terms of the quality and safety of the vaccine. Coordinating Minister for National Covid-19 Immunisation Programme Khairy Jamaluddin said in fact, the NPRA was also described as the most meticulous by the vaccine companies, compared to other international regulatory bodies.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.